Description
CJC-1295 With DAC is studied in experimental models examining its interaction with GHRH receptors (GHRH-R) and associated downstream signaling pathways. Research interest includes analysis of receptor-binding dynamics, prolonged signaling behavior due to DAC modification, and activation of pathways such as cAMP-mediated signaling in controlled in vitro and preclinical models. Investigations may also explore extended peptide half-life characteristics, receptor engagement duration, and effects on signaling persistence. Common laboratory applications include receptor kinetics studies, pathway mapping, and mechanistic evaluation of peptide-mediated endocrine signaling responses.
Overview
CJC-1295 With DAC is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) to extend stability and persistence in controlled research environments. This compound is commonly utilized in laboratory settings focused on peptide pharmacokinetics and receptor interaction studies. This material is provided strictly for analytical and investigational use in controlled research environments. It is not intended for human or veterinary use. Product descriptions are presented for educational and catalog reference purposes only.
Chemical Makeup
Amino Acid Sequence: Modified GRF(1-29) with DAC conjugation
Molecular Formula: Not publicly standardized (DAC-modified peptide)
Molecular Weight: ~3367.9 g/mol (approximate, varies with modification)
CAS Number: 863288-34-0
Reviews
There are no reviews yet.